Preliminary Research Evaluation for Ambulatory Leadless Electrocardiogram Recorder Trial
NCT05357716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2023-10-04
Summary
The clinical study is intended to implement and test the collection and analysis of paired ECG data from the HeartWatch and two comparator devices, an Event Recorder and Holter. The HeartWatch is indicated for extended diagnostic evaluation of patients with transient symptoms of possible cardiac origin such as syncope and palpitations, as well as patients at risk for arrhythmias, but without significant symptoms. While the use of the device itself can be managed by both healthcare professionals and patients, interpretation of the collected data for diagnosis is restricted to healthcare professionals, as the data must be loaded and analyzed separately after recording. Patients indicated for extended ambulatory ECG testing will be approached for participation. Subjects will wear the HeartWatch and an Event Recorder for up to 72 hours or the HeartWatch and Holter monitor for up to 48 hours. Subjects will be asked to document their activities (standing, sitting, walking, exercise, or laying down). Event recorder subjects will collect user-triggered and auto-triggered data, while Holter subjects will record diary information on their activities and any relevant symptoms. Adverse events and user preference for one device versus the other being used in that arm will also be collected from all subjects. Paired ECG data from the HeartWatch and comparator devices is expected to be similar in terms of the events documented and the proportion of data that is clinically interpretable.
Conditions
- Atrial Fibrillation
- Tachycardia, Supraventricular
- Bradyarrhythmia
- Ventricular Arrythmia
Interventions
- DEVICE
-
Event Recorder
A standard 1 or 2-lead Sirona Event Recorder will be used to collect high-resolution data. Subjects will be asked to wear the clinical monitor for at least 48 hours and no longer than 84 hours. ECG signals will be continuously collected as long as the skin patches are attached to the skin and the recorder is properly connected to the wires.
- DEVICE
-
Holter Monitor
A standard 5-lead SEER Holter will be used to collect 3-channels of high-resolution data. Subjects will be asked to wear the clinical, conventional monitor for at least 36 hours and no longer than 60 hours. During this time ECG signals will be continuously collected.
- DEVICE
-
HeartWatch
The HeartWatch arm band provides continuous, high-quality single lead electrocardiograph (ECG) data in a variety of environments. The ECG data is transmitted via Bluetooth and stored on the user's smartphone. It is then uploaded to the cloud for subsequent analysis using either a commercial ECG software package or a customized software package from HelpWear.
Sponsors & Collaborators
-
HelpWear Inc.
lead INDUSTRY
Eligibility
- Min Age
- 22 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-15
- Primary Completion
- 2023-10-02
- Completion
- 2023-10-02
Countries
- Canada
Study Locations
More Related Trials
-
Validation of an iPhone-based Event Recorder for Arrhythmia Detection
NCT02005172 ·Status: COMPLETED ·Phase: NA
-
Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch
NCT06164808 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Precision Event Monitoring for Patients With Heart Failure Using HeartLogic
NCT03579641 ·Status: COMPLETED
-
Wireless Handheld 8-lead ECG Device Performance in Heart Patients (Rapid Rhythm)
NCT03501836 ·Status: COMPLETED ·Phase: NA
-
AVEIR™ Leadless Pacemaker (LP) United Kingdom (UK) Registry
NCT06854484 ·Status: RECRUITING
-
Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2
NCT00180531 ·Status: COMPLETED ·Phase: PHASE4
-
Image Supported Lead Placement in CRT
NCT05053568 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Electrocardiogram Clinical Validation Study
NCT03492554 ·Status: COMPLETED ·Phase: NA
-
BioMonitor Master Study
NCT01725568 ·Status: COMPLETED
-
SMARTHEART Validation Study
NCT04755582 ·Status: UNKNOWN
-
The CT-verified Data Collection Study to Investigate the Correlation Between the Leadless Pacemaker Tip Location and Echo, ECG
NCT06910059 ·Status: ACTIVE_NOT_RECRUITING
-
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251 ·Status: COMPLETED ·Phase: NA
-
Comparison of External Event Recorders for Atrial Fibrillation Monitoring
NCT00863382 ·Status: WITHDRAWN ·Phase: NA
-
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients
NCT04754204 ·Status: COMPLETED
-
Attain Performa(TM) Quadripolar Lead Study
NCT01751022 ·Status: COMPLETED ·Phase: NA
-
Implant of the WiSE CRT System With an Intracardiac Pacemaker
NCT05451797 ·Status: NOT_YET_RECRUITING
-
Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure
NCT01486316 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
NCT03831516 ·Status: COMPLETED
-
Observational Study of the Sleuth Implantable ECG Monitoring System
NCT00717106 ·Status: UNKNOWN
-
Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
NCT03039712 ·Status: ACTIVE_NOT_RECRUITING
-
Measuring Hydration Levels of Healthy and Heart Failure Patients Before, During, and After an Electrophysiology (EP) Procedure
NCT04609683 ·Status: COMPLETED ·Phase: NA
-
Effect of Targeting Left Ventricular Lead Position on the Rate of Response to Cardiac Resynchronization Therapy.
NCT00399594 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data
NCT01161589 ·Status: COMPLETED
-
At-Home Automated External Defibrillator (AED) Training Study
NCT00219674 ·Status: COMPLETED ·Phase: PHASE2
-
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial in Patients With Permanent Atrial Fibrillation
NCT01994252 ·Status: COMPLETED ·Phase: NA